💨 Abstract

South Africa has introduced Wegovy, a weight-loss injection, but its high cost limits access. One in two South African adults is overweight or obese, making the market significant. A month’s supply of Wegovy costs around R3,700, and most medical aid schemes do not cover obesity treatment. Experts warn that high-cost drugs like Wegovy may widen the healthcare gap, benefiting mainly urban, private healthcare patients.

Courtesy: Dumisile Masuku